https://thegbm.com/moonlake-announces-week-40-results-from-its-phase-3-clinical-trials-of-sonelokimab-in-hidradenitis-suppurativa-at-the-2026-aad-annual-meeting/ Business news, opinion, reviews, interviews Sat, 28 Mar 2026 19:00:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4